WEUXGWWSGQTUJD-ICSRJNTNSA-N
C28H28ClF3N6O4 — CID 121351709
Data last refreshed: (MolForge compound catalog, from PubChem)
About WEUXGWWSGQTUJD-ICSRJNTNSA-N
WEUXGWWSGQTUJD-ICSRJNTNSA-N (PubChem CID 121351709) has the molecular formula C28H28ClF3N6O4 and a molecular weight of 605.02 g/mol. Its IUPAC name is (9S)-4-chloro-N-[5-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyrimidin-2-yl]-5-[3-(trifluoromethyl)phenyl]-1,6,8-triazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide.
Molecular Properties
| Compound Name | WEUXGWWSGQTUJD-ICSRJNTNSA-N |
|---|---|
| PubChem CID | 121351709 |
| Molecular Formula | C28H28ClF3N6O4 |
| Molecular Weight | 605.02 g/mol |
| Exact Mass | 604.18 |
| IUPAC Name | (9S)-4-chloro-N-[5-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyrimidin-2-yl]-5-[3-(trifluoromethyl)phenyl]-1,6,8-triazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide |
| SMILES | CC1(C)OC[C@H](COc2cnc(NC(=O)N3c4nc(-c5cccc(C(F)(F)F)c5)c(Cl)cc4N4CCC[C@H]3C4)nc2)O1 |
| InChI | InChI=1S/C28H28ClF3N6O4/c1-27(2)41-15-20(42-27)14-40-19-11-33-25(34-12-19)36-26(39)38-18-7-4-8-37(13-18)22-10-21(29)23(35-24(22)38)16-5-3-6-17(9-16)28(30,31)32/h3,5-6,9-12,18,20H,4,7-8,13-15H2,1-2H3,(H,33,34,36,39)/t18-,20-/m0/s1 |
| InChIKey | WEUXGWWSGQTUJD-ICSRJNTNSA-N |
| XLogP | 5.76 |
| TPSA | 101.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 605.02 |
| LogP ≤ 5 | 5.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121351709 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.